Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Susan Kim-Laubach

Optometrist Pleasanton, CA Doctor of Optometry

NPI 1619003910 CMS profile 164029

5980 Stoneridge Dr, Ste 110, Pleasanton, CA 94588

Open in the dashboard

General payments

$8,088

103 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Susan Kim-Laubach of Pleasanton, CA is reported in the CMS Open Payments database as having received $8,088 across 103 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,651 19
2024 General $1,378 21
2023 General $882 12
2022 General $546 8
2021 General $2,180 23
2020 General $689 9
2019 General $762 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Susan Kim-Laubach
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Susan Kim-Laubach were reported at $1,651. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Susan Kim-Laubach Optometrist median Middle half National median
2019 $762 $159 $67–$371 $163
2020 $689 $72 $29–$165 $114
2021 $2,180 $125 $46–$292 $132
2022 $546 $162 $66–$374 $149
2023 $882 $177 $72–$406 $160
2024 $1,378 $188 $77–$427 $164
2025 $1,651 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alcon Vision LLC $3,671 37 payments
  2. CooperVision Inc. $1,434 27 payments
  3. Bausch & Lomb Americas Inc. $620 6 payments
  4. Bausch & Lomb, a division of Bausch Health US, LLC $392 4 payments
  5. Sun Pharmaceutical Industries Inc. $358 4 payments
  6. Visioneering Technologies, Inc. $350 9 payments
  7. Optos, Inc. $266 2 payments
  8. Heru, Inc. $165 1 payment
  9. Sight Sciences, Inc. $156 4 payments
  10. Tarsus Pharmaceuticals, Inc. $148 1 payment
  11. Other $528 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,166 94 payments
  2. Travel and Lodging $1,661 7 payments
  3. Entertainment $242 1 payment
  4. Gift $19 1 payment
Products named General payments · program years 2019–2025
  1. DAILIES $956 6 payments
  2. AIR OPTIX $952 4 payments
  3. DAILIES TOTAL1 $829 5 payments
  4. TOTAL30 $806 10 payments
  5. MiSight Contact Lens $786 12 payments
  6. Precision 1 $766 7 payments
  7. Multiple Brands Contact Lens $405 9 payments
  8. Cequa $358 4 payments
  9. OCT OPHTHALMOSCOPE $266 2 payments
  10. PANORAMIC OPHTHALMOSCOPE $266 2 payments
  11. Other $3,898 44 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

103 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record